Chinese herbal compound combined with western medicine therapy in the treatment of plasma cell mastitis: A protocol for systematic review and meta-analysis
- PMID: 33126328
- PMCID: PMC7598849
- DOI: 10.1097/MD.0000000000022858
Chinese herbal compound combined with western medicine therapy in the treatment of plasma cell mastitis: A protocol for systematic review and meta-analysis
Abstract
Background: Plasma cell mastitis (PCM) is a benign suppurative disease of the breast based on the expansion of mammary ducts and infiltration of plasma cells. It is relatively rare clinically, and its main manifestations include nonperiodic breast pain, nipple discharge, areola lump, nipple depression, nipple fistula, among others. Modern medicine is mainly surgical treatment, which is easy to recur. The clinical practice shows that the overall treatment of patients with TCM syndrome differentiation using oral medicine combined with western medicine therapy, combined internal and external treatment, can significantly improve the curative effect, prevent recurrence, has a certain therapeutic advantage, but lack of evidence of evidence-based medicine. The purpose of this study is to study the efficacy and safety of oral traditional Chinese medicine (TCM) combined with western medicine therapy in the treatment of PCM.
Methods: Use computer to retrieve English databases (PubMed, Embase, Web of Science, the Cochrane Library) and Chinese databases (CNKI, Wan Fang, VIP, Chinese biomedical database), from the establishment of database to September 2020, for randomized controlled trials(RCTs) of oral TCM combined with western medicine therapy in the treatment of PCM, two researchers independently extracted the data and evaluated the quality of the included research, and meta-analysis was conducted on the included literatures using RevMan5.3 software.
Results: This study evaluated the efficacy and safety of oral TCM combined with western medicine therapy in the treatment of PCM from the aspects of effective rate, symptom score, recurrence rate, adverse reaction rate, and patient satisfaction.
Conclusion: This study will provide reliable evidence-based evidence for the clinical application of oral TCM combined with western medicine therapy in the treatment of PCM.
Ethics and dissemination: The purpose of this study is to sort out and analyze the literature. This systematic review also does not involve endangering participant rights. Ethical approval was not required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER:: doi 10.17605/OSF.IO/K9A78.
Conflict of interest statement
The authors report no conflicts of interest.
Similar articles
-
Efficacy and safety of Xuefu Zhuyu decoction combined with Western medicine for angina pectoris in coronary heart disease: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Dec 11;99(50):e23195. doi: 10.1097/MD.0000000000023195. Medicine (Baltimore). 2020. PMID: 33327236 Free PMC article.
-
Compound Xuanju Capsule combined with western medicine for the treatment of male oligoasthenotspermia: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Oct 16;99(42):e22733. doi: 10.1097/MD.0000000000022733. Medicine (Baltimore). 2020. PMID: 33080731 Free PMC article.
-
The efficacy and safety of Chinese herbal compound combined with western medicine for amyotrophic lateral sclerosis: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Oct 23;99(43):e21933. doi: 10.1097/MD.0000000000021933. Medicine (Baltimore). 2020. PMID: 33120727 Free PMC article.
-
[Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis].Zhong Xi Yi Jie He Xue Bao. 2012 Nov;10(11):1211-28. doi: 10.3736/jcim20121104. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 23158939 Review. Chinese.
-
Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analyses.J Integr Med. 2022 Sep;20(5):416-426. doi: 10.1016/j.joim.2022.06.006. Epub 2022 Jun 24. J Integr Med. 2022. PMID: 35811240 Free PMC article. Review.
Cited by
-
Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis.Exp Biol Med (Maywood). 2022 Jan;247(2):97-105. doi: 10.1177/15353702211049361. Epub 2021 Oct 9. Exp Biol Med (Maywood). 2022. PMID: 34632855 Free PMC article.
-
Corrective surgery for nipple depression in patients with plasmacytic mastitis - A single-center experience.Front Med (Lausanne). 2023 Apr 6;10:1156628. doi: 10.3389/fmed.2023.1156628. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37089608 Free PMC article.
-
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trial.Elife. 2023 Mar 14;12:e84414. doi: 10.7554/eLife.84414. Elife. 2023. PMID: 36917037 Free PMC article. Clinical Trial.
References
-
- Palmieri Andrea, D’Orazi Valerio, Martino Giovanni, et al. Plasma cell mastitis in men: a single-center experience and review of the literature[J]. In Vivo 2016;30:727–32. - PubMed
-
- Ruan H, Yang HJ. Diagnosis and treatment of plasma cell mastitis: a report of 76 cases [J]. Zhejiang Clinical Medical Journal 2003;108.
-
- Thomas WG. The clinical syndrome of mammary duct ectasia. Br J Surg 1982;69:423–5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
